Walker Karen Marie
SEC CIK 2008556 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| KYTX | Kyverna Therapeutics, Inc. | CTO | 46.6K | — | $292.8K | 4 | 2024-06-06 | 2025-12-15 |
Most active insiders at KYTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Westlake BioPartners Opportunity Fund I, L.P. | 10% | $1000.0K | — |
| 2 | SEIDENBERG BETH C | Dir | $1000.0K | — |
| 3 | Walker Karen Marie | CTO | — | $292.8K |
| 4 | GEHCHAN NAJI | See Remarks | — | — |
| 5 | Aktar Mert | Dir | — | — |
| 6 | Biddle Warner Weston | CEO, Dir | — | — |
| 7 | Emany Sravan Kumar | Dir | — | — |
| 8 | Miller Andrew Craig | Dir | — | — |
| 9 | GRASSO MARC | CFO | — | — |
| 10 | Shaw Christi | Executive COB, Dir | — | — |
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2025-12-17 | 2025-12-15 | KYTX | Kyverna Therapeutics, Inc. | Walker Karen Marie | CTO | M - OptEx | $4.83 | +24.0K | 46.6K | +106% | +$115.9K |
| DT | 2025-12-17 | 2025-12-15 | KYTX | Kyverna Therapeutics, Inc. | Walker Karen Marie | CTO | S - Sale+OE | $12.20 | -24.0K | 22.6K | -51% | -$292.8K |
| D | 2025-04-15 | 2025-04-11 | KYTX | Kyverna Therapeutics, Inc. | Walker Karen Marie | CTO | A - Grant | $0.00 | +13.0K | 22.6K | +135% | $0 |
| D | 2024-06-10 | 2024-06-06 | KYTX | Kyverna Therapeutics, Inc. | Walker Karen Marie | CTO | M - OptEx | $4.42 | +9,636 | 9,636 | New | +$42.6K |
Purchase Sale Sale after option exercise All abbreviations